|
|
BGC > Produtos químicos A-Z > (10R,11R)-16-{[(6R,7S,8R,8aS)-7,8-dihydroxy-2-methyl-hexahydro-2H-pyrano[3,2-d][1,3]dioxin-6-yl]oxy}-10-(4-hydroxy-3,5-dimethoxyphenyl)-4,6,13-trioxatetracyclo[7.7.0.0^{3,7}.0^{11,15}]hexadeca-1(9),2
Pesquisa de produto por: (10R,11R)-16-{[(6R,7S,8R,8aS)-7,8-dihydroxy-2-methyl-hexahydro-2H-pyrano[3,2-d][1,3]dioxin-6-yl]oxy}-10-(4-hydroxy-3,5-dimethoxyphenyl)-4,6,13-trioxatetracyclo[7.7.0.0^{3,7}.0^{11,15}]hexadeca-1(9),2
Categorias baseado em (10R,11R)-16-{[(6R,7S,8R,8aS)-7,8-dihydroxy-2-methyl-hexahydro-2H-pyrano[3,2-d][1,3]dioxin-6-yl]oxy}-10-(4-hydroxy-3,5-dimethoxyphenyl)-4,6,13-trioxatetracyclo[7.7.0.0^{3,7}.0^{11,15}]hexadeca-1(9),2:
agents antineoplastic dihydroxy dimethoxyphenyl dioxin dioxol etoposide etoposideetoposide hexadeca hexahydro hydroxy methyl methylhexahydropyrano naphtho pharma pyrano solution tetrahydrofuro trioxatetracyclo
nome IUPAC
CAS
EINECS
Fórmula
33419-42-0
251-509-1
C29H32O13
33419-42-0
251-509-1
C29H32O13
33419-42-0
251-509-1
C29H32O13
33419-42-0
251-509-1
C29H32O13
33419-42-0
251-509-1
C29H32O13
33419-42-0
251-509-1
C29H32O13
33419-42-0
251-509-1
C29H32O13
(10R,11R)-16-{[(6R,7S,8R,8aS)-7,8-dihydroxy-2-methyl-hexahydro-2H-pyrano[3,2-d][1,3]dioxin-6-yl]oxy}-10-(4-hydroxy-3,5-dimethoxyphenyl)-4,6,13-trioxatetracyclo[7.7.0.0^{3,7}.0^{11,15}]hexadeca-1(9),2
33419-42-0
251-509-1
C29H32O13
(5R,5Ar,8aR,9S)-9-(((4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methylhexahydropyrano[3,2-d][1,3]dioxin-6-yl)oxy)-5-(4-hydroxy-3,5-dimethoxyphenyl)-5,5a,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-
33419-42-0
251-509-1
C29H32O13
|
|
|
Como você encontrar novos clientes?
clique aqui
|